Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manolopoulos

Showing results (21-30 of 580) with videos related to

Pageof 58
Sort By:
Physical Review Letters|September 26, 2012
Efficient first-principles calculation of the quantum kinetic energy and momentum distribution of nucleiMichele Ceriotti, David E Manolopoulos
Physical Review. B, Condensed Matter|November 15, 1992
Dielectric losses and ionic conductivity of LiF:Ba2+Grammatikakis, Papathanassiou, Bogris, et al.
Lancet (London, England)|March 2, 2010
ADRB2 Arg16Gly polymorphism in the LARGE trialKonstantinos N Manolopoulos, Fredrik Karpe
Zentralblatt Fur Gynakologie|October 1, 2005
[Endometriosis and infertility]K Manolopoulos, H-R Tinneberg
Current Pharmaceutical Design|September 17, 2009
Drugs targeting atherosclerosis: current and emerging approachesVangelis G Manolopoulos, Anna Tavridou
The Journal of Chemical Physics|December 16, 2011
Thermodynamic integration from classical to quantum mechanicsScott Habershon, David E Manolopoulos
Faraday Discussions|November 30, 2016
Reaction rate theory: summarising remarksDavid Chandler, David E Manolopoulos
Pharmacogenomics|March 28, 2018
From Homer and Hippocrates to modern personalized medicine: is there a role for pharmacoepigenomics in the treatment of alcohol addiction?Georgia Ragia, Vangelis G Manolopoulos
Current Pharmaceutical Design|September 17, 2009
EP2300 compounds: focusing on the antiatherosclerotic properties of squalene synthase inhibitorsA Tavridou, V G Manolopoulos
Current Pharmaceutical Biotechnology|February 28, 2017
Personalized Medicine of Alcohol Addiction: Pharmacogenomics and BeyondGeorgia Ragia, Vangelis G Manolopoulos
Pageof 58

Showing results (21-30 of 580) with videos related to

Sort By:
Pageof 58
Physical Review Letters|September 26, 2012
Efficient first-principles calculation of the quantum kinetic energy and momentum distribution of nucleiMichele Ceriotti, David E Manolopoulos
Physical Review. B, Condensed Matter|November 15, 1992
Dielectric losses and ionic conductivity of LiF:Ba2+Grammatikakis, Papathanassiou, Bogris, et al.
Lancet (London, England)|March 2, 2010
ADRB2 Arg16Gly polymorphism in the LARGE trialKonstantinos N Manolopoulos, Fredrik Karpe
Zentralblatt Fur Gynakologie|October 1, 2005
[Endometriosis and infertility]K Manolopoulos, H-R Tinneberg
Current Pharmaceutical Design|September 17, 2009
Drugs targeting atherosclerosis: current and emerging approachesVangelis G Manolopoulos, Anna Tavridou
The Journal of Chemical Physics|December 16, 2011
Thermodynamic integration from classical to quantum mechanicsScott Habershon, David E Manolopoulos
Faraday Discussions|November 30, 2016
Reaction rate theory: summarising remarksDavid Chandler, David E Manolopoulos
Pharmacogenomics|March 28, 2018
From Homer and Hippocrates to modern personalized medicine: is there a role for pharmacoepigenomics in the treatment of alcohol addiction?Georgia Ragia, Vangelis G Manolopoulos
Current Pharmaceutical Design|September 17, 2009
EP2300 compounds: focusing on the antiatherosclerotic properties of squalene synthase inhibitorsA Tavridou, V G Manolopoulos
Current Pharmaceutical Biotechnology|February 28, 2017
Personalized Medicine of Alcohol Addiction: Pharmacogenomics and BeyondGeorgia Ragia, Vangelis G Manolopoulos
Pageof 58